Language selection

Search

Patent 2039388 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2039388
(54) English Title: METHOD FOR THE SPECIFIC MULTIPLICATION OF NUCLEIC ACID TEMPLATES AND FOR THE DETERMINATION OF NUCLEIC ACIDS
(54) French Title: METHODE POUR LA MULTIPLICATION SPECIFIQUE DE MATRICES D'ACIDES NUCLEIQUES ET LA DETERMINATION DES ACIDES NUCLEIQUES
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12P 19/34 (2006.01)
(72) Inventors :
  • KESSLER, CHRISTOPH (Germany)
  • RUEGER, RUEDIGER (Germany)
(73) Owners :
  • BOEHRINGER MANNHEIM GMBH
(71) Applicants :
  • BOEHRINGER MANNHEIM GMBH (Germany)
(74) Agent: SWABEY OGILVY RENAULT
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1991-03-28
(41) Open to Public Inspection: 1991-10-01
Examination requested: 1991-03-28
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
P 40 10 465.6 (Germany) 1990-03-31

Abstracts

English Abstract


A b s t r a c t
A method for the specific multiplication and for the
detection of nucleic acid templates by hybridization of
two nucleic acid primers to this template, formation of
a nucleic acid complementary to the template with these
primers and transcription of the nucleic acid formed
into a multitude of nucleic acids analogous to the
template, characterised in that the template is
hybridized with two primers which are arranged in the
same orientation, which contain sequences complementary
to the template and of which the second primer carries,
at the end facing away from the first primer, a
transcription-initiation site and a double-stranded
sequence to which a RNA polymerase can bind, the two
primers hybridized in this way are covalently linked to
form a nucleic acid complementary to the template by
filling up the gap between them, transcripts of this
nucleic acid complementary to the template are formed
and, if desired, these transcripts are detected in a
known manner.


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an
exclusive property or privilege is claimed are
defined as follows:
1. A method to specifically multiply a nucleic
acid template by hybridization of two nucleic acid
primers to said template, formation of a nucleic
acid complementary to said template with said
primers and transcription of said formed nucleic
acid into a multitude of nucleic acids analogous to
said template, wherein
(1) said template is hybridized with a first
and a second primer and are separated by a gap,
wherein said primers contain sequences complementary
to said template and of which said second primer
carries, at the end facing away from said first
primer, a transcription-initiation site and a
double-stranded sequence to which RNA polymerase can
bind,
(2) said first and second primers hybridized
in this way are covalently linked to form a nucleic
acid complementary to said template by filling up
said gap between them,
(3) transcripts of said nucleic acid
complementary to said template are formed and
(4) said transcripts are used as templates
and multiplied by repeating (1)-(3).
2. A method for detecting a nucleic acid
template by hybridization of two nucleic acid
primers to said template, formation of a nucleic
acid complementary to said template with said
primers and transcription of said formed nucleic
acid into a multitude of nucleic acids analogous to
said template, wherein

(1) said template is hybridized with a first
and a second primer and are separated by a gap,
wherein said primers contain sequences complementary
to said template and of which said second primer
carries, at the end facing away from said first
primer, a transcription-initiation site and a
double-stranded sequence to which RNA polymerase can
bind,
(2) said first and second primers hybridized
in this way are covalently linked to form a nucleic
acid complementary to said template by filling up
said gap between them,
(3) transcripts of said nucleic acid
complementary to said template are formed,
(4) said transcripts are used as templates
and multiplied by repeating (1)-(3), and
(5) said transcripts are detected.
3. A method as claimed in claim 1, wherein said
template and nucleic acid complementary to said
template are separated before formation of said
transcripts.
4. A method as claimed in claim 2, wherein said
template and nucleic acid complementary to said
template are separated before formation of said
transcripts.
5. A method as claimed in claim 3, wherein said
separation of said template and nucleic acid
complementary to said template occurs by RNaseH
digestion.
6. A method as claimed in claim 4, wherein said
separation of said template and nucleic acid

complementary to said template occurs by RNaseH
digestion.
7. A method ad claimed in claim 1, 2, 3, 4, 5,
or 6 wherein said template is DNA.
8. A method as claimed in claim 1, 2, 3, 4, 5,
or 6, wherein said template is RNA.
9. A method as claimed in claim 1, 2, 3, 4, 5 or
6, wherein said template is converted into a single-
stranded form before hybridization with said
primers.
10. A method as claimed in claim 7, wherein said
template is converted into a single-stranded form
before hybridization with said primers.
11. A method as claimed in claim 1, 2, 3, 4, 5 or
6, wherein a double-stranded DNA template is cleaved
with at least one restriction endonuclease and is
converted into the single-stranded form.
12. A method as claimed in claim 7, wherein a
double-stranded DNA template is cleaved with at
least one restriction endonuclease and is converted
into the single-stranded form.
13. A method as claimed in claim 1, 2, 3, 4, 5,
6, 10, or 12, wherein said double-stranded sequence
of said second primer has a length of 17-100
complementary bases.
14. A method as claimed in claim 7, wherein said
double-stranded sequence of said second primer has a
length of 17-100 complementary bases.

15. A method as claimed in claim 8, wherein said
double-stranded sequence of said second primer has a
length of 17-100 complementary bases.
16. A method as claimed in claim 9, wherein said
double-stranded sequence of said second primer has a
length of 17-100 complementary bases.
17. A method as claimed in claim 11, wherein said
double-stranded sequence of said second primer has a
length of 17-100 complementary bases.
18. A method as claimed in claim 13, wherein said
complementary bases of said double-stranded sequence
is linked together via a nucleic acid fragment of 5-
100 bases.
19. A method as claimed in claim 14, 15, 16 or
17, wherein said complementary bases of said double-
stranded sequence is linked together via a nucleic
acid fragment of 5-100 bases.
20. A method as claimed in claim 1, 2, 3, 4, 5,
6, 10, 12, 14, 15, 16, 17 or 18, wherein said second
primer has a phosphorylated 5' end and said double-
stranded sequence facing said first primer has a
dideoxynucleotide-terminated 3' end.
21. A method as claimed in claim 7, wherein said
second primer has a phosphorylated 5' end and said
double-stranded sequence facing said first primer
has a dideoxynucleotide-terminated 3' end.
22. A method as claimed in claim 8, wherein said
second primer has a phosphorylated 5' end and said

double-stranded sequence facing said first primer
has a dideoxynucleotide-terminated 3' end.
23. A method as claimed in claim 9, wherein said
second primer has a phosphorylated 5' end and said
double-stranded sequence facing said first primer
has a dideoxynucleotide-terminated 3' end.
24. A method as claimed in claim 11, wherein said
second primer has a phosphorylated 5' end and said
double-stranded sequence facing said first primer
has a dideoxynucleotide-terminated 3' end.
25. A method as claimed in claim 13, wherein said
second primer has a phosphorylated 5' end and said
double-stranded sequence facing said first primer
has a dideoxynucleotide-terminated 3' end.
26. A method as claimed in claim 19, wherein said
second primer has a phosphorylated 5' end and said
double-stranded sequence facing said first primer
has a dideoxynucleotide-terminated 3' end.

Description

Note: Descriptions are shown in the official language in which they were submitted.


Method for the specific multiplication of nucleic
acid templates and for the determination of nucleic
acids.
i
The subject matter of the invention is a method for
the specific multiplication of nucleic acid
templates and a method for the determination of
nucleic acids.
Method for the specific multiplication of nucleic
acid templates are described for example in
EP A 0 200 362, Mullis et al., filed March 27, 1986
in the name of Hoffmann-La Roche AG. There it is
proposed that the nucleic acid to be detected is
multiplied by an in vitro system. For this at least
one primer is added to the sample for each nucleic
acid single strand to be multiplied. Starting from
the primer a nucleic acid strand is formed by an
enzymatic elongation reaction which is complementary
to each of the nucleic acid single strands. This
reaction can be carried out several times one after
the other whereby the newly formed nucleic acid
strands can also be multiplied. A disadvantage of
this method is that a heating step is necessary
between each multiplication step.
En EP-A 0329 822, Davey et al., filed August 26,
1988 in the name of Cangene Corporation, a method is
described for multiplying specific nucleic acid
templates by hybridization of two nucleic acid
primers to this template, template-dependent
formation of DNA with these primers and transcrip-
tion of this DNA into a multitude of nucleic acids
which are analogous to the template. A disadvantage
of this method is in particular that the method
~:: , :; .
, .
, :,, ::..', ' '' ' ,'
,

- la -
required long incubation periods at relatively high
temperatures. In addition -the method is only
,
,~ : : . . :
. .
~: "~. , :,, :
: :.: . :: ~

2 ~
- z -
suitable for the multiplication of DNA after complicated
pre-treatment of the template.
The present inven-tion seeks to eliminate the
aforementioned disadvantages of the state of the art and
to provide a simpler, particularly sensitive method for
the multiplication and for the specific detection of
nucleic acid templates.
The subject matter of the invention is a method for the
specific multiplication of nucleic acid templates by
hybridization of two nucleic acid primers to this
template, formation of a nucleic acid complementary to
the template with these primers and transcription of the
nucleic acid formed into a multitude of nucleic acids
analogous to the template, which is characterized in
that,
the template is hybridized with two primers which
are arranged in the same orientation, which aontain
sequences complementary to the template and of
which the second primer carries, at the end facing
away from the first primer, a transcription-
initiation site and a double-stranded sequence to
which a RNA polymerase can bind,
the two primers hybridized in this way are
covalently linked to form a nucleic acid
complementary to the template by filling up the gap
between them and transcripts (nucleic acids which
are analogous to the template) are formed of this
nucleic acid complementary to the template.
,. . . ..... . . . . . .
- : ,: , ,, " , , ,: ~ ,
, "
' ,.:, ' ' , ,
,, , ': ~ ;; , ~, ;
,: , ,:
. .
, " , , , : ':

2~3~38~
-- 3
.,
In a preferred embodiment the transcripts which are
formed are usecl again as templates for hybridization
with the primers and the multiplication cycle is
repeated. In a further preferred embodiment additional
primers can be used, in particular ~o improve the
specificity, which have a region complementary to the
template which is di~ferent to ~hat region of the
primer used in the first cycle.
In the sense of the invention nucleic acid templates are
understood as DNA and RN~ originating from prokaryotes
or eukaryotes. These also include viral and bacterial
nucleic acids as well as nucleic acids from viroids.
They can be single-or double-stranded~ They can be
episomal nucleic acids, such as plasmids, or genomic
chromosomal nucleic acids. The nucleic acids can be
characteri~tic for a particular organism or a group of
organisms.
The nucleic acids can also be used as a crude lysate or
purified (e.g. by phenol extraction or
guanidine/isothiocyanate gradient centrifugation).
Modified nucleic acids can, however, also be used such
as nucleic acids cut by means of restriction enzymes or
nucleic acids modified by exonuclease treatment. In the
cas~ of RNA, cDNA can be produced beforehand. It has
proved to be advantageous if the nucleic acids are in
the form of single strands or are converted into a
single-stranded form before carrying out the reaction.
A primer is understood as a nucleotide sequence which
contains se~uences complementary to the nucleic acid
template and can hybridize by this means with
a portion of the
,, - . : . ,:, . ,.: ,,~. , :-: . ..... .
:,
.: , .: .
- , : . ;, :

~3~33~
template under stringent conditions (e.g. Anal. Biochem.
138 (19~4) 267-284).
A nucleic acid complementary to the template is
understood as a nucleic acid which is complementary to
the template i~ at least one section. A nucleic acid
analogous to the template i5 understood as a nucleic
acid which has been produced by means o~ the
multiplication method and, as a result, at least one
section corresponds to the complementary sequences to
the primers and to the filled up gap sequence, in which
the sequence is homologous to the template sequence.
A nucleic acid fragment which contains a complementary
se~uence to the template with pxeferably 15 - 40,
particularly preferably 16 - 25 bases i9 used as the
second primer. A transcription initiation site and a
double-stranded sequence to which a RNA polymerase can bind
is contiguous to this single-stranded sequence containing
the complementary sequence. The double-stranded sequence
has preferably a length of 17 - LOO bases, particularly
pre~erably 7 - 50 bases. Both strands of the double-
stranded part can either be present in an open form or
the two ends which face away from the sequence
complementary to the template can be connected via a
~urther nucleic acid sequence which pre~erably has a
length of 5 - 100, particularly preferably 5 - 10 bases
and preferably represents a polynucleotide.
In a preferred embodiment the section of the second
primer sequence which is complementary to the template
begins with a phosphorylated 5' end at the end facing
towards the first primer. It is equally preferred that
the 3' end facing the first primer ends with a
dideoxynucleotide which is particularly preferably
- ,, ~ ; " , ,
,

2~39388
complementary to the transcription initiation sike or to
the last (3') nucleotide of the promoter sequence.
Suitable double-stranded sequences to which a RNA
polymerase can bind are for example described in Melton
et al., NAR 12 (1984) 7035-7056, Pfeiffer, and Gilbert
W., Protein Sequences and DNA Analysis 1 (1988) 269-280.
The first primer contains sequences complementary to the
template which enable a hybridization of the primer to
the template under stringent conditions (see above).
Those conditions are preferred under which the primer
only binds to primer-specific sequences in the template
nucleic acid.
The length of the complementaxy regions of the primer is
preferably 15 - 40, in particular 16 - 25 bases.
In a further preferred embodiment one of the two primers
contains a covalently-bound partner of a biological
binding pair at its end which faces away from the other
primer. In addition, or as an alternative, the
transcription of the nucleic acids complementary to the
template into the nucleic acids analogous to the
template can be carried out using mononucleotides which
contain inco~porated a partner of a biological binding pair
instead of the unmodified mononucleotides. The nucleic
acids complementary to the template or/and the
transcripts which are formed can then be removed from
the reaction solution and immobilized via the other
binding partner which is immobilized on a carrier. The
nucleic acids immobilized in this way can then be
detected for example by methods which are familiar to
one skilled in the art.
. ::
, . ,
.. .. .
. . : ~

2~3~
Examples of suitable binding pairs are biotin-
~treptavidin or avidin, hapten-antibody, antigen-
antibody, concanavalin-antibody, sugar-lectin or
complementary nucleic acids. Complementary nucleic acids
having a length of 5 to 100, preferably 10 - 30 bases
are preferably used.
In a preferred embodiment khe method is used for the
multiplication of speci~ic DNA templates and specific
RNA templates. If the DNA template is present as a
double-strand, the template is pxeferably converted
before hybridization into the single-stranded ~orm by
methods which are well-known to one skilled in the art.
In a preferred embodiment the nucleic acid to be
multiplied or to be determined is converted before
hybridization with the primers into a modified template
by treatment with restiction endonucleases or
exonucleases.
In a further preferred embodiment template and
DNA complementary to the template are separated
before production of the transcript. This is
preferably carried out with a RNase~. RNaseH from
E. coli or from calf thymus is particularly preferably
used.
The concentration of the RNaseH is preferably
0.5 - 2 U/reaction volume.
The multiplicakion is preferably carried out at 30 -
37C for 30 min to 2 hours. The reaction volume is
preferably chosen as 25 - 100 ~1. The concentration of
the primer is preferably 0.3 - 3.5 ~mol/l in each case.
.: . - ,. ~ : ,
. ~ , ' ,. , ' ,: . ~ :
~, ~
.. . .

2~3~3~
-- 7
In order to fill up the gap between the primers a ligase
and reverse transcriptase are preferably used. T4 ligase
is particularly preferably used as the ligase. The
concentration o~ the ligase is preferably between 1 and
10 U/reaction volume. The gap can also be closed- by
addition of a suitable oligonucleotide and linkage with
ligase. When ligases are added a cofactor, for example
ATP for T4 ligase or NAD~ for E. coli ligase, must be
added.
The concentration of the reverse transcriptase is
preferably O - 30 U/test volume. MoMLV or AMV reverse
transcriptase is preferably used as the reverse
transcriptase.
The production of the transcripts is carried out by
addition 3~ RNA polymerase. A phage-coded RNA
polymerase, such as for example T7 ~NA polymerase, T3
RNA polymerase or SP6 RNA polymerase is preferably used.
The concentration of the polymerase i5 preferably 10 -
100 U/reaction volume.
The invention also provides a method for the detection
of nucleic acid templates by hybridization of two
nucleic acid primers to this template, formation of a
nucleic acid complementary to the template with these
primers and transcription of the nucleic acid formed
into a multitude of nucleic acids analogous to the
template, characterized in that
the template is hybridized with two primers which
are arranged in the same orientatlon, which contain
sequences complementary to the template and of
which the second primer carries, at the end facing
, ...
:,: :.. .
- : :
,: : ,
- : . : :
. . . : ,
.:: ::
.

~938~
~ 8 --
away from the first primer, a transcription-
initiation site and a double-stranded sequence to
which a RNA polymerase can bind,
the two primers hybridized in this way are
covalently linked to form a nucleic acid
complementary to the kemplate by ~illing up the gap
between them,
transcripts are formed from this nucleic acid
complementary to the template and these transcripts
are detected in a known manner (e.g. Molecular
Cloning ~982, Eds. Maniatis et al., p. 199-206).
The preferred embodiments of th~ method of detection are
analogous t~ those of the multiplication method.
The subsequent purification, or the detection of the
transcription products formed, can be carried out as
described above by an immobilization and subsequent
detection with suitable methods. It is equally suitable
to separate the transcription products by gel
electrophoresis, to stain ths RN.~ and to visualize
either directly or by Northern transfer and subsequently
to hybridize with labelled probes specific for a target
sequence. Equally suitable are dot-, blot/slot-, blot-
hybridization methods with labelled probes specific for
a target sequence and labelling of the transcription
products with one or several NTPs which are labelled for
example radioactively, fluorescently or with enzymes.
The products can be made directly visible in dot-, slot-
or Northern blot by incorporating 32P-labelled or non-
radioactively labelled NTPs. The incorporation of
, :, ~ . : . : :
:' , , ' ~ ' ' :,-' ;,' ~'' ' '
. ..
,

~938~
g
digoxigenin or biotin (cf. WO 89/06698) can be used for the
direct detection using a biological binding partner direc-
-ted against digoxigenin or biotin, for example an anti-
di~oxigenin an-tibody.
Fig. 1 shows the nucleotide sequence of the first primer
used in Example 1.
Fig 2 shows two variants ~or the second primer.
Fig. 3 shows a preferred variant of a detection method
for nucleic acids according to the present invention.

-- 10 --
The following examples and the figures elucidate the
invention further:
Example
Production of RNA -templates
The plasmid pSPT18 (sequence cf. W0 89/06698, Holtke et al.,
filed January 12, 1989 in the name of ~oehringe~ M~elm GmbH) is used
for the production of transcripts of the neomycin
resistance gene (neo). The neomycin gene (an amino
glycoside-3'-phosphotransferase II) is inserted into
this plasmid as described in Beck et al, Gene 19 (1982)
327 - 336. Using the resultant plasmid pSPT18neo
transcripts of the gene in the sense orientation can be
produced using SP6 RNA pol~nerase. The plasmid pSPT18neo
is linearized with BglI. RNA transcripts which are
employed as templates in Éxample 2 are produced from
this linearized plasmid by in vitro transcription as
described in Biochemicals for Molecular Biology,
Boehringer Mannheim (1987) page 38 - 40.
Example 2
. . .
RNA amplification
a) Production of the primers 1 and 2
The sequence for the primer 1 (DNA oligonucleotide
of 24 nucleotides, Fig. 1) is complementary to a
region of the mRNA of the neo gene which according
to Beck et al corresponds to the nuc]eotides 2008 -
2031 o~ the DNA sequence. The sequence of primer 2
(also 24 nucleotides, Fig. 2) corresponds to the
' :, '"
, . ,, ~, :
: , . ,
...
:, , ~ ;
:: ' ' '

nucleotide positions 1937 - 1960 of the neo gene.
In addition primer 2 contains the minimum necessary
double-stranded sequence of the promoter for the
RNA polymerase of bacteriophage T7 (T7 RNAP,
sequence c~. Fig. 2) (Uhlenbeck et al., Nature, 328
(1987) 596 - 600). In addition primer 2 contains an
AT-rich loop region which stabilizes the partial
double strand. Two functional variants of the
primer sequence are shown in Fig. 2 (ddA or ddG at
the 3' ends)~ Primer 2 is phosphorylated at the 5'
end, as described for example in Maxam and Gilbert
in Methods in Enzymology Volume 60 (1980) p. 499
and Nucleic Acids Research 3 (1976) 863. In
addition ddA or ddG are added at the 3' end as also
described there.
Amplification reaction
Reaction mixture:
40 mmol/l Tris ~ICl (pH 8 at 37C),
10 mmol/l DTT,
1 mmolll spermidine,
0.01 ~ Triton X 100,
8 % polyethylene glycol,
20 mmol/l MgCl2,
1 mmol/l ATP,
2 mmol/l each NTPs
1 mmol/l each dNTPs,
500 nmol/l primer-1,
1 ~mol/l primer 2,
5 U/reaction volume T4 ligase,
40 U/reaction volume T7 RNAP,
20 U/reaction volume reverse transcriptase and
1 U/reaction volume RNaseH.
*trade-mark
,, ,. _. .
' ,; ".,, " '; ,' ' ; ':,
' . ' :
... . .

2~3~
The non-enzymatic substances used are pre-treated be~ore
use with 0.1 % diethylpyrocarbonate analogous to
Maniatis (see below) pages 7.3 - 7.4.
The sample ~RNA fragment according to Example 1 or
dilutions thereof) is added to a reaction vessel of
50 ~1 volume and the vessel is filled up with the
reaction mixture.
The preparation is incubated for two hours at 37c, the
RNA produced is precipitated with ethanol, separated in
a RNA gel, dyed and trans~erred onto a nylon membrane as
described in Molecular Cloning, 1989, editors Sambrook
et al., CSH, pages 7.43 - 1.51. The membrane-bound RNA
can be detected with neo-specific probes which are
labelled with digoxigenin (produced according to "DNA
Labelling and Detection", Boehringer Mannheim GmbH,
1989, pages 27 - 28 or according to W0 89/06698).
" . ': .,' , . :
- : , ~ ,,
, ' : : ,

Representative Drawing

Sorry, the representative drawing for patent document number 2039388 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2018-01-01
Inactive: IPC from MCD 2006-03-11
Time Limit for Reversal Expired 1998-03-30
Application Not Reinstated by Deadline 1998-03-30
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1997-04-01
Application Published (Open to Public Inspection) 1991-10-01
All Requirements for Examination Determined Compliant 1991-03-28
Request for Examination Requirements Determined Compliant 1991-03-28

Abandonment History

Abandonment Date Reason Reinstatement Date
1997-04-01
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BOEHRINGER MANNHEIM GMBH
Past Owners on Record
CHRISTOPH KESSLER
RUEDIGER RUEGER
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 1991-10-01 5 162
Drawings 1991-10-01 2 47
Cover Page 1991-10-01 1 23
Abstract 1991-10-01 1 29
Descriptions 1991-10-01 13 436
Fees 1995-02-21 1 82
Fees 1994-02-28 1 61
Fees 1996-02-27 1 63
Fees 1993-02-18 1 65
Prosecution correspondence 1991-03-28 1 37
Prosecution correspondence 1993-11-30 3 85
Prosecution correspondence 1995-12-06 3 98
Courtesy - Office Letter 1991-12-16 1 48
Examiner Requisition 1995-06-09 2 106
Examiner Requisition 1993-06-09 2 90